- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Intensive care medicine. - 50, 6 (2024) , 1010-1012, ISSN: 1432-1238
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2024
- DOI
-
10.1007/s00134-024-07432-5
- URN
-
urn:nbn:de:bsz:25-freidok-2469230
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-03-25T13:45:51+0100
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
Time of origin
- 2024
Other Objects (12)
Routine colonoscopy in patients with high risk of non-occlusive mesenteric ischemia
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Correction: Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP) - a single center, open-label, three-arm, randomized, controlled intervention trial
Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP) — Aasingle center, open‐label, three‐arm, randomized, controlled intervention pilot trial
"A wolf in sheep's clothing"
The wolf in sheep's clothing
"A wolf in sheep's clothing"
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Klinisches Vorgehen bei Leberabszessen
Routine colonoscopy in patients with high risk of non-occlusive mesenteric ischemia
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Correction: Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP) - a single center, open-label, three-arm, randomized, controlled intervention trial
Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP) — Aasingle center, open‐label, three‐arm, randomized, controlled intervention pilot trial
"A wolf in sheep's clothing"
The wolf in sheep's clothing
"A wolf in sheep's clothing"
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Klinisches Vorgehen bei Leberabszessen
Routine colonoscopy in patients with high risk of non-occlusive mesenteric ischemia
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Correction: Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP) - a single center, open-label, three-arm, randomized, controlled intervention trial
Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP) — Aasingle center, open‐label, three‐arm, randomized, controlled intervention pilot trial
"A wolf in sheep's clothing"
The wolf in sheep's clothing
"A wolf in sheep's clothing"
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab